An anonymous director reports

NANALYSIS SCIENTIFIC CORP. ANNOUNCES GRANT OF RESTRICTED SHARE UNITS

Nanalysis Scientific Corp.'s board of directors has granted 475,000 restricted share units (RSUs) to its independent directors, pursuant to the company's RSU plan. Each RSU is exercisable for one common share in the capital of the company for a period ending at the end of the calendar year, three years after the date of grant. One hundred thousand of the RSUs vest immediately, and the remaining RSUs vest as to one-third on each of the 12-month, 24-month and 36-month anniversary of the date of grant.

About Nanalysis Scientific Corp.

Nanalysis's business is what it terms "MRI (magnetic resonance imaging) and NMR (nuclear magnetic resonance) for industry." The company develops and manufactures portable nuclear magnetic resonance (NMR) spectrometers or analyzers for laboratory and industrial markets. The NMReady-60 was the first full-feature portable NMR spectrometer in a single compact enclosure requiring no liquid helium or any other cryogens. The company has followed up that initial offering with new products and continues to have a strong innovation pipeline. In 2020 Nanalysis announced the launch of its 100-megahertz device, the most powerful and most advanced compact NMR device ever brought to market.

Nanalysis's devices are used in many industries (oil and gas, chemical, mining, pharma, biotech, flavour and fragrances, agrochemicals, law enforcement, and more) as well as numerous government and university research labs around the world. The company continues to exploit new global market opportunities independently and with partners.

In 2022 the company acquired K'(Prime) Technologies Inc., a North American sales and service company which provides sales services for scientific instrumentation for pharma, food, chemical, and oil and gas customers, as well as imaging systems for security applications. K'Prime's service organization provides airport and commercial security installation and maintenance solutions across North America.

Additionally in 2022, the company acquired a 43-per-cent ownership in Quad Systems AG, a Zurich-based nuclear magnetic resonance company focused on high-field NMR for pharmaceutical and other vertical markets.

We seek Safe Harbor.